| [1] |
Heerspink HJL, Andress DL, Bakris G, et al. Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: a clinical trial design novel to diabetic nephropathy [J]. Diabetes Obes Metab, 2018, 20(6): 1369-1376.
|
| [2] |
Kobayashi K, Shibata M, Kato K. Diabetic nephropathy [J]. Naika, 1971, 27(6): 1431-1437.
|
| [3] |
Hoffmann S, Podlich D, Hahnel B, et al. Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats [J]. J Am Soc Nephrol, 2004, 15(6): 1475-1487.
|
| [4] |
Singh L, Singh G, Dinda AK. Understanding podocytopathy and its relevance to clinical nephrology [J]. Indian J Nephrol, 2015, 25(1): 1-7.
|
| [5] |
Hartleben B, Godel M, Meyer-Schwesinger C, et al. Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice [J]. J Clin Invest, 2010, 120(4): 1084-1096.
|
| [6] |
Mori H, Inoki K, Masutani K, et al. The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential [J]. Biochem Biophys Res Commun, 2009, 384(4): 471-475.
|
| [7] |
Yang Y, Wang J, Qin L, et al. Rapamycin prevents early steps of the development of diabetic nephropathy in rats [J]. Am J Nephrol, 2007, 27(5): 495-502.
|
| [8] |
Asanuma K, Tanida I, Shirato I, et al. MAP-LC3, a promising autophagosomal marker, is processed during the differentiation and recovery of podocytes from PAN nephrosis [J]. FASEB J, 2003, 17(9): 1165-1167.
|
| [9] |
Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues [J]. Cell, 2011, 147(4): 728-741.
|
| [10] |
Levine B, Yuan J. Autophagy in cell death: an innocent convict? [J]. J Clin Invest, 2005, 115(10): 2679-2688.
|
| [11] |
Klionsky DJ, Abeliovich H, Agostinis P, et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes [J]. Autophagy, 2008, 4(2): 151-175.
|
| [12] |
Weide T, Huber TB. Implications of autophagy for glomerular aging and disease [J]. Cell Tissue Res, 2011, 343(3): 467-473.
|
| [13] |
Shankland SJ. The podocyte′s response to injury: role in proteinuria and glomerulosclerosis [J]. Kidney Int, 2006, 69(12): 2131-2147.
|
| [14] |
Velagapudi C, Bhandari BS, Abboud-Werner S, et al. The tuberin/mTOR pathway promotes apoptosis of tubular epithelial cells in diabetes [J]. J Am Soc Nephrol, 2011, 22(2): 262-273.
|